Carlo Previderè
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Carlo Previderè has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Sapino
INOC - Istituto Nazionale Oncologico Candiolo; IRCCS, Candiolo, Italy
1 shared publication - Barbara Di Stefano
Department of Medicine, Surgery and Health, University of Trieste, 34149 Trieste, Italy
1 shared publication - Caterina Marchiò
Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
1 shared publication - Eros Azzalini
Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy
1 shared publication - Paolo Fattorini
Department of Medicine, Surgery and Health, University of Trieste, 34149 Trieste, Italy
1 shared publication - Serena Bonin
DSM—Department of Medical Sciences, University of Trieste, 34149 Trieste, Italy
1 shared publication
Latest Publications
- Open Access
- 7 May 2024
- Published by MDPI AG in Methods and Protocols
- Vol. 7 (3) , 40
Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study
Archive tissues are the most available source of human tissues useful for molecular analysis in translational research. The main issues for those specimens are the modification and degradation of biomolecules, namely proteins, DNA, and RNA. In the last decade, several high-throughput analytical methods have been applied to archive tissues. Although histological tissues are fixed in neutral-buffered formalin nowadays, in the recent past, Bouin’s solution was also used in tissue processing. The present study aims to investigate the feasibility of nCounter Nanostring hybridization in quantifying mRNA in highly degraded samples, such as Bouin’s fixed and paraffin-embedded (BFPE) tissues, in comparison to the standard formalin-fixed and paraffin-embedded (FFPE) tissues as a source of RNA. A total of 16 paraffin-embedded tissue blocks from eight patients were analyzed (8 were FFPE and 8 were BEPE). Nanostring technology was applied to 300 ng of each RNA sample, whereas 360 ng of the same templates were retrotranscribed and submitted to qPCR and ddPCR. Our results show that the Nanostring technology outperforms the reference methods (ddPCR and qPCR) in detecting target mRNA in FFPE and BFPE samples. However, even Nanostring technology does not escape the limitation imposed by the degradation of the RNA templates, which could lead to misleading conclusions on the gene expression level.
- 7 May 2024
- Published by MDPI AG in Methods and Protocols
- Vol. 7 (3) , 40
Open AccessQuantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study
Archive tissues are the most available source of human tissues useful for molecular analysis in translational research. The main issues for those specimens are the modification and degradation of biomolecules, namely proteins, DNA, and RNA. In the last decade, several high-throughput analytical methods have been applied to archive tissues. Although histological tissues are fixed in neutral-buffered formalin nowadays, in the recent past, Bouin’s solution was also used in tissue processing. The present study aims to investigate the feasibility of nCounter Nanostring hybridization in quantifying mRNA in highly degraded samples, such as Bouin’s fixed and paraffin-embedded (BFPE) tissues, in comparison to the standard formalin-fixed and paraffin-embedded (FFPE) tissues as a source of RNA. A total of 16 paraffin-embedded tissue blocks from eight patients were analyzed (8 were FFPE and 8 were BEPE). Nanostring technology was applied to 300 ng of each RNA sample, whereas 360 ng of the same templates were retrotranscribed and submitted to qPCR and ddPCR. Our results show that the Nanostring technology outperforms the reference methods (ddPCR and qPCR) in detecting target mRNA in FFPE and BFPE samples. However, even Nanostring technology does not escape the limitation imposed by the degradation of the RNA templates, which could lead to misleading conclusions on the gene expression level.